Exogenous expression of MEF2D/BCL9 in a B-ALL cell line promoted cell growth, increased the expression of HDAC9 (a known MEF2D target), and induced resistance to dexamethasone [60]. The gene discussed is MEF2D; the disease is acute lymphoblastic leukemia.